Experts from across The Conversation assess the work that’s helped us reach vaccine roll-out, how this could play out, and the risk of vaccine hesitancy.
Academic rigour, journalistic flair
Articles on Vaccine hesitancy
Displaying 161 - 180 of 203 articles
Employers could require their workers to get vaccinated against COVID-19 via both workplace policies and existing laws. Neither option, however, is simple or straightforward.
Health workers are at greater risk from the virus and play a key role in promoting vaccination themselves – so uptake needs to be high.
Vaccine hesitancy is not new, but it has a new element: few people can remember the devastating impact of diseases such as smallpox and polio and it is hard to see the lives saved by vaccination.
Combating social media disinformation regarding vaccines is critical to reversing the growth in vaccine hesitancy around the world.
We shouldn’t paint all those hesitant or unsure about new medical treatments with the same broad brush. We need a more productive and thoughtful conversation.
There are arguments both for and against making vaccination compulsory.
The United Nations recently asked a group of experts across the world to recommend ways to persuade people to take a COVID-19 vaccine. Here is a summary of their suggestions.
COVID-19 vaccines are at risk of being undermined by vaccine hesitancy. Pharma must take steps to ensure transparency in data monitoring committees and trial data to build public trust in vaccines.
Mistrust of the medical establishment, based on experience, is behind hesitancy.
As viruses are transmitted from person to person they are constantly mutating and replicating. Could the SARS-CoV-2 virus evolve to evade the new vaccines that have just been developed?
New research confirms findings from before the pandemic: that vaccine hesitancy often coincides with broader anti-scientific thinking.
People who oppose vaccines often are dismissed as ignorant or naive. Failing to hear their concerns and address them may only be fueling vaccine resistance, however.
A safe, effective COVID-19 vaccine is expected to be developed in record time and may be approved for production, distribution and acceptance some time in 2021.
Experts from across The Conversation look at how COVID-19 vaccines will work, how they’re being tested and manufactured, and what challenges there will be to rolling them out.
From 2017 to 2019, Twitter users in the United States saw many tweets related to vaccination but only rarely encountered anti-vaccine content and almost never saw content from bots.
Australians who refuse vaccines spend a lot of time trying to understand vaccine choices and think they’re making evidence-based decisions.
Governments need to engage not just with anti-vaxxers, but with concerns about the safety and environmental impact of vaccines
Several vaccines are in Phase 3 trials. So when will we know whether any of these will protect against COVID-19?
Clear messages from experts helped New Zealand to contain COVID-19 outbreaks. The same is now necessary to counter vaccine misinformation and to build public trust in vaccination.
Top contributors
-
Assistant Professor of Political Science, Oklahoma State University
-
Associate professor, UNSW Sydney
-
Research Fellow, Vaccine Uptake Group, Murdoch Children's Research Institute
-
Paediatrician at the Royal Childrens Hospital and Associate Professor and Clinician Scientist, University of Melbourne and MCRI, Murdoch Children's Research Institute
-
Associate Professor, School of Social Sciences, The University of Western Australia
-
Regional Adviser, Immunisation, WHO Regional Office for Africa, Stellenbosch University
-
Professor, Susan Wakil School of Nursing and Midwifery, University of Sydney
-
Executive Director, African Population and Health Research Center
-
Assistant Professor of Health Policy and Managment, School of Public Health, Texas A&M University
-
Senior Lecturer, School of Communication, Journalism and Marketing, Massey University
-
Senior Scientist, Cochrane South Africa, South African Medical Research Council (SAMRC) and Honorary researcher, Division of Social & Behavioural Sciences, School of Public Health, UCT, South African Medical Research Council
-
Director, Center for Public Interest Communications, University of Florida
-
Associate Professor, The University of Western Australia
-
Senior Research Fellow, Oxford Uehiro Centre for Practical Ethics, University of Oxford
-
Visiting Professor in Biomedical Ethics, Murdoch Children's Research Institute; Distinguished Visiting Professor in Law, University of Melbourne; Uehiro Chair in Practical Ethics, University of Oxford
